Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132587) titled 'Real-World Outcomes of Resected NSCLC patients treated with Adjuvant EGFR-TKI in China (ECHO)' on Sept. 16.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)
Condition:
Non-small cell lung cancer (NSCLC)
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-22
Target Sample Size: Observation group:2000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=324838
Published by HT Digital Content Services with permission from Health...